ACTG2 Inhibits Growth and Is Epigenetically Repressed in Small Intestinal Neuroendocrine Tumors Abstract #820

Introduction: Small intestinal neuroendocrine tumors (SI-NETs) originate from the enterochromaffin cells in the ileum. Actin gamma smooth muscle 2 (ACTG2) is downregulated in lymph node metastases from SI-NETs. ACTG2 and microRNA-145 (miR-145) are aberrantly expressed in other cancers and ACTG2 can be induced by miRNA-145.
Aim(s): To investigate the cause for downregulation and function of ACTG2 in SI-NETs.
Materials and methods: ACTG2 protein expression was analyzed in SI-NETs (n=24) by immunohistochemistry. The SI-NET cell line CNDT2.5 was treated with 3-deazaneplanocin (DZNep), a selective EZH2 inhibitor (EPZ-6438) and a DNA hypomethylating agent (5-aza-dC). Cells were transfected with ACTG2 plasmid and miR-145. Western blotting analysis, qRT-PCR, colony-forming and viability assays were performed, and miR-145 expression levels measured in tumor samples (n=24).
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Basic Science - Genetics, epigenetics, miRNAs
Presenting Author: PhD candidate Katarina Edfeldt

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result